PMID- 21329899 OWN - NLM STAT- MEDLINE DCOM- 20110613 LR - 20220331 IS - 1876-7591 (Electronic) IS - 1876-7591 (Linking) VI - 4 IP - 2 DP - 2011 Feb TI - Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. PG - 150-6 LID - 10.1016/j.jcmg.2010.11.015 [doi] AB - OBJECTIVES: The aim of this study was to compare the reproducibility of 7 late gadolinium enhancement (LGE) quantification techniques across 3 conditions in which LGE is known to be important: acute myocardial infarction (AMI), chronic myocardial infarction (CMI), and hypertrophic cardiomyopathy (HCM). BACKGROUND: LGE by cardiac magnetic resonance is the gold-standard technique for assessing myocardial scar. No consensus exists on the best method for its quantification, and research in this area is scant. Techniques include manual quantification, thresholding by 2, 3, 4, 5, or 6 SDs above remote myocardium, and the full width at half maximum (FWHM) technique. To date, LGE has been linked to outcome in 3 conditions: AMI, CMI, and HCM. METHODS: Sixty patients with 3 LGE etiologies (AMI, n = 20; CMI, n = 20; HCM, n = 20) were scanned for LGE. LGE volume was quantified using the 7 techniques. Mean LGE volume, interobserver and intraobserver reproducibility, and impact on sample size were assessed. RESULTS: LGE volume varied significantly with the quantification method used. There was no statistically significant difference between LGE volume by the FWHM, manual, and 6-SD or 5-SD techniques. The 2-SD technique generated LGE volumes up to 2 times higher than the FWHM, 6-SD, and manual techniques. The reproducibility of all techniques was worse in HCM than AMI or CMI. The FWHM technique was the most reproducible in all 3 conditions compared with any other method (p < 0.001). Use of the FWHM technique for LGE quantification in paired analysis would lead to at least a 60% reduction in required sample size compared with any other method. CONCLUSIONS: Regardless of the disease under study, the FWHM technique for LGE quantification gives LGE volume mean results similar to manual quantification and is statistically the most reproducible, reducing required sample sizes by up to one-half. CI - Copyright (c) 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. FAU - Flett, Andrew S AU - Flett AS AD - Department of Cardiology, The Heart Hospital, University College London Hospitals NHS Trust, London, UK. FAU - Hasleton, Jonathan AU - Hasleton J FAU - Cook, Christopher AU - Cook C FAU - Hausenloy, Derek AU - Hausenloy D FAU - Quarta, Giovanni AU - Quarta G FAU - Ariti, Cono AU - Ariti C FAU - Muthurangu, Vivek AU - Muthurangu V FAU - Moon, James C AU - Moon JC LA - eng GR - FS/08/012/24454/BHF_/British Heart Foundation/United Kingdom GR - FS/08/028/24767/BHF_/British Heart Foundation/United Kingdom GR - FS/10/72/28568/BHF_/British Heart Foundation/United Kingdom PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - JACC Cardiovasc Imaging JT - JACC. Cardiovascular imaging JID - 101467978 RN - 0 (Contrast Media) RN - 0 (Organometallic Compounds) RN - 6HG8UB2MUY (Meglumine) RN - L0ND3981AG (gadoterate meglumine) SB - IM CIN - JACC Cardiovasc Imaging. 2011 Feb;4(2):157-60. PMID: 21329900 CIN - JACC Cardiovasc Imaging. 2011 Nov;4(11):1223; author reply 1224. PMID: 22093276 MH - Adult MH - Aged MH - Cardiomyopathy, Hypertrophic/complications/*diagnosis/pathology MH - Cicatrix/*diagnosis/etiology/pathology MH - Contrast Media MH - Female MH - Humans MH - Image Interpretation, Computer-Assisted MH - London MH - *Magnetic Resonance Imaging MH - Male MH - Meglumine MH - Middle Aged MH - Myocardial Infarction/complications/*diagnosis/pathology MH - Myocardium/*pathology MH - Observer Variation MH - Organometallic Compounds MH - Predictive Value of Tests MH - Reproducibility of Results MH - Retrospective Studies EDAT- 2011/02/19 06:00 MHDA- 2011/06/15 06:00 CRDT- 2011/02/19 06:00 PHST- 2010/09/08 00:00 [received] PHST- 2010/10/26 00:00 [revised] PHST- 2010/11/22 00:00 [accepted] PHST- 2011/02/19 06:00 [entrez] PHST- 2011/02/19 06:00 [pubmed] PHST- 2011/06/15 06:00 [medline] AID - S1936-878X(10)00837-5 [pii] AID - 10.1016/j.jcmg.2010.11.015 [doi] PST - ppublish SO - JACC Cardiovasc Imaging. 2011 Feb;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015.